JA FY25-0155 Redacted.pdf

CUI

Control Number: FY25-0155

Controlled by: Defense Health Agency (DHA) Controlled by: USAMRAA

CUI Category: Procurement and Acquisition – General Procurement and Acquisition

Limited Dissemination Control: FED ONLY POC: Jeffrey Sprecher, 301-619-2327

CUI

Source Selection Information - See FAR 2.101 and 3.104-4

NOV 2024

Sole Source Justification (SSJ) for Requirements under the Simplified Acquisition Threshold

1. Identification of the Agency and Contracting Activity: The United States Army Medical Research Acquisition Activity (USAMRAA) R&D Contracts Division 2 at Fort Detrick, 820 Chandler Street, Fort Detrick, MD 21702

2. Description of Action:

New Requirement Purchase Order Blanket Purchase Agreement (BPA) Order against BPA # Click or tap here to enter text.

Order against Multiple Award Indefinite Delivery, Indefinite Quantity (IDIQ) Contract # Click or tap here to enter text.

Order against Single Award IDIQ Contract # Click or tap here to enter text.

Order against Federal Supply Schedule Contract # Click or tap here to enter text.

Follow-on Requirement to Contract/Order # Click or tap here to enter text.

Modification against existing Contract/Order and Modification # Click or tap here to enter text.

Contract Type Fixed Price Time & Materials/Labor Hours Cost Reimbursable Hybrid Click or tap here to enter text.

Name of Proposed Contractor(s) and Address:

Agilent Technologies 2850 Centerville RD Wilmington, Delaware

Control Number: FY25-0028

Source Selection Information - See FAR 2.101 and 3.104-4

NOV 2024

3. Description of Services or Supplies and Estimated Value:

The Armed Forces Medical Examiner System (AFMES) requires relocation and installation of two (2) Agilent Ultivo Triple Quad Mass Spectrometers.

Total Value:

4. Authority:

FAR 13.106-1(b)(1): For purchases not exceeding the simplified acquisition threshold, only one source reasonably available (e.g., urgency, exclusive licensing agreements, brand-name, or industrial mobilization).

5. Reason for Authority Cited:

The requirement is for relocation service and installation contract for designated Agilent Technologies equipment located at Lackland Air Force Base. This contract must cover the packing at HQ AFDTL Lackland AFB, transportation to AFMES at Dover AFB, and the installation of the instruments in the DFT laboratory at Dover AFB. Agilent Technologies is the Original Equipment Manufacturer and the only vendor capable of providing packing and installation services, in order to ensure the equipment’s performance, calibration, and functionality are not compromised. Failure to award this requirement to Agilent Technologies could invalidate current standardized analytical drug testing procedures and would result in numerous man-hours being used to correct any deficiencies. The method validation process would take weeks to months to complete and during this time the DFT would not be able to report any case results. This type of stoppage would be detrimental to all military contributors worldwide and delay the release of death certificates, testing results for ground flight crews involved in mishaps, and delay all criminal and fit for duty investigations. Failure to award this contract immediately could lead to suspended laboratory testing which impacts missions throughout the DoD.

A Sole Source requirement is essential for AFMES DFT to maintain operation capabilities. The AFMES DFT mission provides toxicological examination for military autopsies, aircraft incidents, criminal investigations (including drug-facilitated sexual assaults and DUI/DWI), fitness-for-duty inquiries, and selected cases of national interest. Each year the DFT processes more than 15,000 cases, many of which directly affect operational readiness and/or national security. The results obtained from these instruments require exacting accuracy and precision.

Agilent, the Original Equipment Manufacturer (OEM) has the direct expertise to insure the high reliability in operation and reporting. OEM field service representatives are directly trained and updated on new procedures and packing, transportation and reinstallation completed by the OEM preserves current existing Warranties for the equipment. Due to the nature of our mission and the exactness required in performing various drug screening/testing procedures, it is imperative that

NOV 2024

Agilent Technologies be awarded this contract to ensure the instrument’s performance, calibration, and functionality are not compromised during relocation and installation services.

Agilent Technologies currently provides services on contract , but relocation services are not included. These services will save the Department of Defense (DoD) and the Drug Demand Reduction Program (DDRP) the cost of purchasing new Ultivo Triple Quad Mass Spectrometers for AFMES. The estimated cost savings will be

6. Market Research:

Market research was conducted February 2025 and included the following techniques:

Contacted knowledgeable people (Government and industry) in specific markets.

Querying the Government-wide database of contracts and other procurement instruments intended for use by multiple agencies available at https://www.contractdirectory.gov/contractdirectory/ and other Government and commercial databases that provide information relevant to agency acquisitions

Obtaining source lists of similar items from other contracting activities or agencies, trade associations or other sources.

Reviewing catalogs and other generally available product literature published by manufacturers, distributors, and dealers or available on-line.

7. Other Facts:

a. Procurement History:

(1) Is this a new requirement? Yes

(2) If 7.a.(1) is No, was the action just prior to this one competed? Not Applicable

(3) If 7.a.(2) is Yes, what has changed where this action cannot be competed? Not Applicable

b. Additional Information: Not applicable

NOV 2024

8. Technical Certification:

I certify the supporting data under my cognizance, which are included in the justification, are accurate and complete to the best of my knowledge and belief.

9. Requirements Certification:

I certify the supporting data under my cognizance, which are included in the justification, are accurate and complete to the best of my knowledge and belief.

NOV 2024

10. Fair and Reasonable Cost Determination:

I hereby determine the anticipated cost to the Government for this contract action will be fair and reasonable.

Basis for Determination: Determining price reasonableness shall be accomplished by price analysis; comparing quoted pricing to the Independent Government Estimate (IGE) and or previous purchases of like items.

11. Contracting Officer Determination:

I certify this justification is accurate and complete to the best of my knowledge and belief.